Aterian (ATER) Q2 2026 earnings summary

Executive summary

• Completed sale of marquee consumer brands for $18.0 million and issued $7.0 million in preferred stock, resulting in a change of control and new CEO appointment.

• All outstanding debt under the credit facility was repaid and the company now focuses on legacy brands Vremi and Xtava.

• Substantial doubt remains about the ability to continue as a going concern due to limited scale and ongoing macroeconomic challenges.

Financial highlights

• Net revenue from continuing operations fell 91.9% year-over-year to $7,000 for Q2 2026; discontinued operations revenue was $13.3 million, down 31.4%.

• Net loss for Q2 2026 was $0.5 million, a significant improvement from $4.9 million loss in Q2 2025, driven by income from discontinued operations.

• Gross profit margin from discontinued operations rose to 77.3% from 54.3% due to tariff refunds and product mix.

• Operating loss from continuing operations was $4.0 million for Q2 2026, up 10.6% year-over-year.

• Cash and restricted cash at June 30, 2026 was $3.7 million, down from $11.7 million at year-end 2025.

Outlook and guidance

• Management plans to drive operational efficiencies, optimize supply chain, and evaluate strategic alternatives.

• No formal financial guidance provided; future viability depends on scaling legacy brands or executing a strategic transaction.